There were no cures for degenerative disorders like Alzheimer's disease. A recent work in the UK offers a way out. A hormone, Interleukin-1 (IL-1), thought to benefit head injuries, is not benign. By administering a receptor antagonistic to IL-1, the neurodegeneration was reduced.
We are a voice to you; you have been a support to us. Together we build journalism that is independent, credible and fearless. You can further help us by making a donation. This will mean a lot for our ability to bring you news, perspectives and analysis from the ground so that we can make change together.
Comments are moderated and will be published only after the site moderator’s approval. Please use a genuine email ID and provide your name. Selected comments may also be used in the ‘Letters’ section of the Down To Earth print edition.